Your browser doesn't support javascript.
loading
A Set of Experimentally Validated Decoys for the Human CC Chemokine Receptor 7 (CCR7) Obtained by Virtual Screening.
Proj, Matic; De Jonghe, Steven; Van Loy, Tom; Jukic, Marko; Meden, Anze; Ciber, Luka; Podlipnik, Crtomir; Groselj, Uros; Konc, Janez; Schols, Dominique; Gobec, Stanislav.
Afiliação
  • Proj M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • De Jonghe S; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Van Loy T; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Jukic M; Faculty of Chemistry and Chemical Engineering, Laboratory of Physical Chemistry and Chemical Thermodynamics, University of Maribor, Maribor, Slovenia.
  • Meden A; Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Koper, Slovenia.
  • Ciber L; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Podlipnik C; Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
  • Groselj U; Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
  • Konc J; Faculty of Chemistry and Chemical Technology, University of Ljubljana, Ljubljana, Slovenia.
  • Schols D; National Institute of Chemistry, Ljubljana, Slovenia.
  • Gobec S; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Front Pharmacol ; 13: 855653, 2022.
Article em En | MEDLINE | ID: mdl-35370691
ABSTRACT
We present a state-of-the-art virtual screening workflow aiming at the identification of novel CC chemokine receptor 7 (CCR7) antagonists. Although CCR7 is associated with a variety of human diseases, such as immunological disorders, inflammatory diseases, and cancer, this target is underexplored in drug discovery and there are no potent and selective CCR7 small molecule antagonists available today. Therefore, computer-aided ligand-based, structure-based, and joint virtual screening campaigns were performed. Hits from these virtual screenings were tested in a CCL19-induced calcium signaling assay. After careful evaluation, none of the in silico hits were confirmed to have an antagonistic effect on CCR7. Hence, we report here a valuable set of 287 inactive compounds that can be used as experimentally validated decoys.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article